EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Early Outcomes of Real-World Transcatheter Tricuspid Valve Replacement

Domenico Angellotti, Isabel Mattig, Daryoush Samim, Björn Goebel, Charlotte Jantsch, Barbara Rubinic, Tobias Ruf, Tobias Geisler, Mirjam Kessler, Matti Adam, Lukas Stolz, Varius Dannenberg und 17 weitere

JACC: Cardiovascular Interventions · 2025-08 · 18 (15) · 1896-1909

DOI: 10.1016/j.jcin.2025.06.002 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025-08. Verfasst von Domenico Angellotti und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland; Department of Advanced Biomedical Sciences, University of …. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Tricuspid Valve, Heart Valve Prosthesis Implantation, Cardiac Catheterization. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Transcatheter tricuspid valve replacement (TTVR) has been recently approved for the treatment of patients with severe tricuspid regurgitation (TR). Real-world evidence regarding the commercial use of TTVR is lacking. OBJECTIVES: The aim of this study was to investigate the real-world safety and efficacy of the EVOQUE TTVR system in patients with severe TR treated at 12 experienced heart valve centers in 5 European countries. METHODS: Consecutive patients treated with the EVOQUE system since approval in Europe (October 2023 to February 2025) were included in this retrospective analysis. Clinical outcomes were assessed at 30-day follow-up. RESULTS: The study included 176 patients (mean age 77.8 years, 72.0% women, median TRI-SCORE 5 points [IQR: 2 points]). At a median follow-up time of 30 days (IQR: 2 days), severe or greater TR was reduced to mild or none in 126 of 128 patients (98.4%; P < 0.001). NYHA functional class improved from 20.2% (28 of 138) class I or II at baseline to 79.7% (110 of 138; P) at 1 month (P < 0.001), with signs of improved hepatorenal function (estimated glomerular filtration rate 47.0 ± 19.9 mL/min/1.73 m2 vs 53.7 ± 23.3 mL/min/1.73 m2 [P < 0.001]; bilirubin 14.2 ± 8.8 μmol/L vs 11.0 ± 9.8 μmol/L [P < 0.001]). Massive or torrential TR at baseline was more common among patients who improved compared with those with stable or worsening NYHA functional class (75 of 98 [76.5%] vs 20 of 40 [50.0%]; P = 0.004). Permanent pacemaker implantation was required in 21 of 111 pacemaker-naive patients (18.9%), in particular those with conduction disturbances at baseline (OR: 4.53; 95% CI: 1.73-11.82; P = 0.002). Moderate or severe right ventricular dysfunction was an independent predictor of clinical failure at 1-month follow-up (OR: 3.60; 95% CI: 1.39-9.32, P = 0.008). CONCLUSIONS: TR elimination following TTVR in a real-world setting was associated with significant symptom and end-organ functional improvement. Patients with massive or torrential TR were more likely to experience functional improvement. Pre-existing conduction disturbances are associated with increased risk for pacemaker implantation, while baseline right ventricular dysfunction is a strong predictor of adverse clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tricuspid Valve InsufficiencyTricuspid ValveHeart Valve Prosthesis ImplantationCardiac CatheterizationHumansFemaleMaleAgedRetrospective StudiesTreatment OutcomeTime FactorsEuropeSeverity of Illness IndexRecovery of FunctionHeart Valve ProsthesisAged, 80 and overRisk FactorsProsthesis DesignHemodynamics

Stichwörter der Autor:innen

postmarketreal worldstructuraltranscatheter tricuspid valve implantationtranscatheter tricuspid valve replacementtricuspid regurgitationtricuspid valvevalvular heart disease

Autor:innen und Institutionen

  • Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
  • Deutsches Herzzentrum der Charité, Berlin, Germany.
  • Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Ox…
  • Department of Cardiology, Heart Center of the Central Clinic Bad Berka, Bad Berka, Germany.
  • Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
  • Department of General and Interventional Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany; Heart and Diabetes Center North Rhine-Westphalia, Medizinische Faku…

Zitieren

APA

Angellotti, D., Mattig, I., Samim, D., Goebel, B., Jantsch, C., Rubinic, B., Ruf, T., Geisler, T., Kessler, M., Adam, M., Stolz, L., Dannenberg, V., Kassar, M., Stathogiannis, K., Cesario, V., Dumonteil, N., Chrissoheris, M., Spargias, K., Baldus, S., …, & Praz, F. (2025). Early Outcomes of Real-World Transcatheter Tricuspid Valve Replacement. JACC: Cardiovascular Interventions, 18(15), 1896-1909. https://doi.org/10.1016/j.jcin.2025.06.002

Vancouver

Angellotti D, Mattig I, Samim D, Goebel B, Jantsch C, Rubinic B, et al. Early Outcomes of Real-World Transcatheter Tricuspid Valve Replacement. JACC: Cardiovascular Interventions. 2025;18(15):1896-1909. doi:10.1016/j.jcin.2025.06.002

BibTeX
@article{Angellotti2025,
  author = {Angellotti, Domenico and Mattig, Isabel and Samim, Daryoush and Goebel, Björn and Jantsch, Charlotte and Rubinic, Barbara and Ruf, Tobias and Geisler, Tobias and Kessler, Mirjam and Adam, Matti and Stolz, Lukas and Dannenberg, Varius and Kassar, Mohammad and Stathogiannis, Konstantinos and Cesario, Vincenzo and Dumonteil, Nicolas and Chrissoheris, Michael and Spargias, Konstantinos and Baldus, Stephan and Rottbauer, Wolfgang and Gerçek, Muhammed and Bartko, Philippe M and Lapp, Harald and Dreger, Henryk and Hausleiter, Jörg and Lurz, Philipp and Windecker, Stephan and Rudolph, Volker and Praz, Fabien},
  title = {Early Outcomes of Real-World Transcatheter Tricuspid Valve Replacement},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  volume = {18},
  number = {15},
  pages = {1896--1909},
  doi = {10.1016/j.jcin.2025.06.002}
}
Kostenlos starten →